107 related articles for article (PubMed ID: 10513561)
1. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
Westkaemper RB; Runyon SP; Bondarev ML; Savage JE; Roth BL; Glennon RA
Eur J Pharmacol; 1999 Sep; 380(1):R5-7. PubMed ID: 10513561
[TBL] [Abstract][Full Text] [Related]
2. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist.
Peddi S; Roth BL; Glennon RA; Westkaemper RB
Eur J Pharmacol; 2003 Dec; 482(1-3):335-7. PubMed ID: 14660041
[TBL] [Abstract][Full Text] [Related]
3. Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
Runyon SP; Savage JE; Taroua M; Roth BL; Glennon RA; Westkaemper RB
Bioorg Med Chem Lett; 2001 Mar; 11(5):655-8. PubMed ID: 11266163
[TBL] [Abstract][Full Text] [Related]
4. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
Runyon SP; Peddi S; Savage JE; Roth BL; Glennon RA; Westkaemper RB
J Med Chem; 2002 Apr; 45(8):1656-64. PubMed ID: 11931619
[TBL] [Abstract][Full Text] [Related]
5. Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor.
Westkaemper RB; Runyon SP; Savage JE; Roth BL; Glennon RA
Bioorg Med Chem Lett; 2001 Feb; 11(4):563-6. PubMed ID: 11229772
[TBL] [Abstract][Full Text] [Related]
6. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.
Westkaemper RB; Glennon RA
Curr Top Med Chem; 2002 Jun; 2(6):575-98. PubMed ID: 12052195
[TBL] [Abstract][Full Text] [Related]
7. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
[TBL] [Abstract][Full Text] [Related]
8. 9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.
Shah JR; Mosier PD; Peddi S; Roth BL; Westkaemper RB
Bioorg Med Chem Lett; 2010 Feb; 20(3):935-8. PubMed ID: 20045641
[TBL] [Abstract][Full Text] [Related]
9. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
Runyon SP; Mosier PD; Roth BL; Glennon RA; Westkaemper RB
J Med Chem; 2008 Nov; 51(21):6808-28. PubMed ID: 18847250
[TBL] [Abstract][Full Text] [Related]
10. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
[TBL] [Abstract][Full Text] [Related]
11. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists.
Glennon RA; Metwally K; Dukat M; Ismaiel AM; De los Angeles J; Herndon J; Teitler M; Khorana N
Curr Top Med Chem; 2002 Jun; 2(6):539-58. PubMed ID: 12052193
[TBL] [Abstract][Full Text] [Related]
12. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
[TBL] [Abstract][Full Text] [Related]
13. [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
Neuropharmacology; 1998 Sep; 37(9):1147-58. PubMed ID: 9833645
[TBL] [Abstract][Full Text] [Related]
14. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.
Shah JR; Mosier PD; Roth BL; Kellogg GE; Westkaemper RB
Bioorg Med Chem; 2009 Sep; 17(18):6496-504. PubMed ID: 19700330
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
Wang CD; Gallaher TK; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
[TBL] [Abstract][Full Text] [Related]
18. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes.
Nishio H; Inoue A; Nakata Y
Arch Int Pharmacodyn Ther; 1996; 331(2):189-202. PubMed ID: 8937629
[TBL] [Abstract][Full Text] [Related]
19. Mutations of transmembrane IV and V serines indicate that all tryptamines do not bind to the rat 5-HT2A receptor in the same manner.
Johnson MP; Wainscott DB; Lucaites VL; Baez M; Nelson DL
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):1-6. PubMed ID: 9387857
[TBL] [Abstract][Full Text] [Related]
20. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
Boksa J; Mokrosz MJ; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Wesołowska A; Misztal S
Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
